1	TGFbeta1	TGFbeta1	B-NP	NN	B-protein	0	ROOT	-1
2	,	,	O	,	O	1	P	-1
3	back	back	B-ADVP	RB	O	1	NMOD	-1
4	to	to	B-PP	TO	O	3	AMOD	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	future	future	I-NP	NN	O	4	PMOD	-1
7	:	:	O	:	O	1	P	-1
8	revisiting	revisit	B-VP	VBG	O	1	NMOD	-1
9	its	its	B-NP	PRP$	O	10	NMOD	-1
10	role	role	I-NP	NN	O	8	OBJ	0
11	as	as	B-PP	IN	O	8	VMOD	-1
12	a	a	B-NP	DT	O	15	NMOD	-1
13	transforming	transform	I-NP	VBG	B-protein	15	NMOD	-1
14	growth	growth	I-NP	NN	I-protein	15	NMOD	0
15	factor	factor	I-NP	NN	I-protein	11	PMOD	-1
16	.	.	O	.	O	1	P	-1

1	TGFbeta1	TGFbeta1	B-NP	NN	B-protein	2	SUB	-1
2	was	be	B-VP	VBD	O	0	ROOT	-1
3	initially	initially	I-VP	RB	O	2	VMOD	-1
4	identified	identify	I-VP	VBN	O	2	VC	-1
5	in	in	B-PP	IN	O	4	VMOD	-1
6	culture	culture	B-NP	NN	O	7	NMOD	0
7	media	medium	I-NP	NNS	O	5	PMOD	-1
8	from	from	B-PP	IN	O	7	NMOD	-1
9	transformed	transform	B-NP	VBN	B-cell_line	10	NMOD	0
10	cells	cell	I-NP	NNS	I-cell_line	8	PMOD	-1
11	as	as	B-PP	IN	O	4	VMOD	-1
12	part	part	B-NP	NN	O	11	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	a	a	B-NP	DT	O	15	NMOD	-1
15	factor	factor	I-NP	NN	O	13	PMOD	-1
16	that	that	B-NP	WDT	O	15	NMOD	-1
17	could	could	B-VP	MD	O	16	SBAR	-1
18	produce	produce	I-VP	VB	O	17	VC	0
19	a	a	B-NP	DT	O	21	NMOD	-1
20	transformed	transform	I-NP	VBN	O	21	NMOD	0
21	phenotype	phenotype	I-NP	NN	O	18	OBJ	-1
22	in	in	B-PP	IN	O	18	VMOD	-1
23	a	a	B-NP	DT	O	26	NMOD	-1
24	nontransformed	nontransformed	I-NP	JJ	B-cell_line	26	NMOD	-1
25	cell	cell	I-NP	NN	I-cell_line	26	NMOD	-1
26	line	line	I-NP	NN	I-cell_line	22	PMOD	-1
27	.	.	O	.	O	2	P	-1

1	Subsequently	Subsequently	B-ADVP	RB	O	4	VMOD	-1
2	this	this	B-NP	DT	O	3	NMOD	-1
3	activity	activity	I-NP	NN	O	4	SUB	0
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	separated	separate	I-VP	VBN	O	4	VC	-1
6	into	into	B-PP	IN	O	5	VMOD	-1
7	TGFbeta	TGFbeta	B-NP	NN	B-protein	9	NMOD	-1
8	and	and	I-NP	CC	O	9	NMOD	-1
9	TGFalpha	TGFalpha	I-NP	NN	B-protein	6	PMOD	-1
10	an	an	B-NP	DT	O	13	NMOD	-1
11	EGF	EGF	I-NP	NN	O	13	NMOD	-1
12	receptor	receptor	I-NP	NN	O	13	NMOD	-1
13	ligand	ligand	I-NP	NN	O	5	VMOD	-1
14	.	.	O	.	O	4	P	-1

1	With	With	B-PP	IN	O	29	VMOD	-1
2	the	the	B-NP	DT	O	3	NMOD	-1
3	discovery	discovery	I-NP	NN	O	1	PMOD	-1
4	that	that	B-SBAR	IN	O	3	NMOD	-1
5	TGFbeta1	TGFbeta1	B-NP	NN	B-protein	6	SUB	-1
6	was	be	B-VP	VBD	O	4	SBAR	-1
7	a	a	B-NP	DT	O	10	NMOD	-1
8	potent	potent	I-NP	JJ	O	10	NMOD	-1
9	growth	growth	I-NP	NN	O	10	NMOD	4	growth
10	inhibitor	inhibitor	I-NP	NN	O	6	PRD	0
11	of	of	B-PP	IN	O	10	NMOD	-1
12	epithelial	epithelial	B-NP	JJ	B-cell_type	13	NMOD	-1
13	cells	cell	I-NP	NNS	I-cell_type	11	PMOD	-1
14	,	,	O	,	O	29	P	-1
15	and	and	O	CC	O	17	NMOD	-1
16	the	the	B-NP	DT	O	17	NMOD	-1
17	identification	identification	I-NP	NN	O	29	SUB	-1
18	of	of	B-PP	IN	O	17	NMOD	-1
19	inactivating	inactivate	B-VP	VBG	O	20	NMOD	18	inactivating
20	mutations	mutation	B-NP	NNS	O	18	PMOD	-1
21	within	within	B-PP	IN	O	20	NMOD	-1
22	the	the	B-NP	DT	O	25	NMOD	-1
23	TGFbeta1	TGFbeta1	I-NP	NN	B-protein	25	NMOD	-1
24	signaling	signaling	I-NP	NN	O	25	NMOD	0
25	pathway	pathway	I-NP	NN	O	21	PMOD	0
26	in	in	B-PP	IN	O	25	NMOD	-1
27	cancers	cancer	B-NP	NNS	O	26	PMOD	-1
28	it	it	B-NP	PRP	O	29	SUB	-1
29	became	become	B-VP	VBD	O	0	ROOT	-1
30	clear	clear	B-ADJP	JJ	O	29	PRD	-1
31	that	that	B-SBAR	IN	O	29	VMOD	-1
32	TGFbeta1	TGFbeta1	B-NP	NN	B-protein	33	NMOD	-1
33	signaling	signaling	I-NP	NN	O	34	SUB	0
34	is	be	B-VP	VBZ	O	31	SBAR	-1
35	a	a	B-NP	DT	O	38	NMOD	-1
36	tumor	tumor	I-NP	NN	O	38	NMOD	-1
37	suppressor	suppressor	I-NP	NN	O	38	NMOD	0
38	pathway	pathway	I-NP	NN	O	34	PRD	0
39	for	for	B-PP	IN	O	38	NMOD	-1
40	early	early	B-NP	JJ	O	41	NMOD	-1
41	stages	stage	I-NP	NNS	O	39	PMOD	-1
42	of	of	B-PP	IN	O	41	NMOD	-1
43	cancer	cancer	B-NP	NN	O	42	PMOD	-1
44	.	.	O	.	O	29	P	-1

1	However	However	B-NP	RB	O	5	VMOD	-1
2	many	many	I-NP	JJ	O	4	NMOD	-1
3	human	human	I-NP	JJ	O	4	NMOD	-1
4	carcinomas	carcinoma	I-NP	NNS	O	5	SUB	-1
5	overexpress	overexpres	B-VP	VBP	O	9	VMOD	9	overexpress
6	TGFbeta1	TGFbeta1	B-NP	NN	B-protein	5	OBJ	-1
7	and	and	O	CC	O	9	VMOD	-1
8	this	this	B-NP	DT	O	9	SUB	-1
9	is	be	B-VP	VBZ	O	0	ROOT	-1
10	associated	associate	I-VP	VBN	O	9	VC	0
11	with	with	B-PP	IN	O	10	VMOD	-1
12	poor	poor	B-NP	JJ	O	14	NMOD	-1
13	patient	patient	I-NP	NN	O	14	NMOD	-1
14	prognosis	prognosis	I-NP	NN	O	17	NMOD	-1
15	and	and	O	CC	O	17	NMOD	-1
16	increased	increase	B-NP	VBN	O	17	NMOD	17	increased
17	frequency	frequency	I-NP	NN	O	11	PMOD	-1
18	of	of	B-PP	IN	O	17	NMOD	-1
19	metastasis	metastasis	B-NP	NN	O	18	PMOD	14	metastasis
20	.	.	O	.	O	9	P	-1

1	Similar	Similar	B-NP	JJ	O	2	NMOD	-1
2	results	result	I-NP	NNS	O	3	SUB	0
3	have	have	B-VP	VBP	O	0	ROOT	-1
4	been	be	I-VP	VBN	O	3	VC	-1
5	obtained	obtain	I-VP	VBN	O	4	VC	0
6	with	with	B-PP	IN	O	5	VMOD	-1
7	tumor	tumor	B-NP	NN	B-cell_line	9	NMOD	-1
8	cell	cell	I-NP	NN	I-cell_line	9	NMOD	-1
9	lines	line	I-NP	NNS	I-cell_line	13	NMOD	-1
10	and	and	O	CC	O	13	NMOD	-1
11	experimental	experimental	B-NP	JJ	O	13	NMOD	-1
12	animal	animal	I-NP	NN	O	13	NMOD	-1
13	models	model	I-NP	NNS	O	6	PMOD	-1
14	.	.	O	.	O	3	P	-1

1	Thus	Thus	B-NP	RB	O	7	VMOD	-1
2	stage	stage	I-NP	NN	O	4	NMOD	-1
3	specific	specific	I-NP	JJ	O	4	NMOD	-1
4	duality	duality	I-NP	NN	O	7	SUB	-1
5	of	of	B-PP	IN	O	4	NMOD	-1
6	function	function	B-NP	NN	O	5	PMOD	-1
7	is	be	B-VP	VBZ	O	0	ROOT	-1
8	the	the	B-NP	DT	O	10	NMOD	-1
9	emerging	emerge	I-NP	VBG	O	10	NMOD	-1
10	paradigm	paradigm	I-NP	NN	O	7	PRD	-1
11	for	for	B-PP	IN	O	10	NMOD	-1
12	the	the	B-NP	DT	O	13	NMOD	-1
13	role	role	I-NP	NN	O	11	PMOD	16	role
14	of	of	B-PP	IN	O	13	NMOD	-1
15	TGFbeta1	TGFbeta1	B-NP	NN	B-protein	14	PMOD	-1
16	in	in	B-PP	IN	O	13	NMOD	-1
17	cancer	cancer	B-NP	NN	O	16	PMOD	-1
18	.	.	O	.	O	7	P	-1

1	This	This	B-NP	DT	O	2	NMOD	-1
2	review	review	I-NP	NN	O	3	SUB	-1
3	will	will	B-VP	MD	O	0	ROOT	-1
4	focus	focus	I-VP	VB	O	3	VC	-1
5	on	on	B-PP	IN	O	4	VMOD	-1
6	the	the	B-NP	DT	O	7	NMOD	-1
7	evidence	evidence	I-NP	NN	O	5	PMOD	-1
8	for	for	B-PP	IN	O	7	NMOD	-1
9	TGFbeta1	TGFbeta1	B-NP	NN	B-protein	8	PMOD	-1
10	as	as	B-PP	IN	O	7	NMOD	-1
11	a	a	B-NP	DT	O	13	NMOD	-1
12	tumor	tumor	I-NP	NN	O	13	NMOD	-1
13	promoting	promoting	I-NP	NN	O	16	NMOD	17	promoting
14	and	and	O	CC	O	16	NMOD	-1
15	metastasis	metastasis	B-NP	NN	O	16	NMOD	14	metastasis
16	factor	factor	I-NP	NN	O	10	PMOD	-1
17	and	and	O	CC	O	4	VMOD	-1
18	examine	examine	B-VP	VB	O	4	VMOD	-1
19	the	the	B-NP	DT	O	23	NMOD	-1
20	biological	biological	I-NP	JJ	O	22	AMOD	-1
21	and	and	I-NP	CC	O	22	AMOD	-1
22	molecular	molecular	I-NP	JJ	O	23	NMOD	-1
23	basis	basis	I-NP	NN	O	18	OBJ	-1
24	for	for	B-PP	IN	O	23	NMOD	-1
25	these	these	B-NP	DT	O	26	NMOD	-1
26	effects	effect	I-NP	NNS	O	24	PMOD	0
27	.	.	O	.	O	3	P	-1

1	It	It	B-NP	PRP	O	2	SUB	-1
2	is	be	B-VP	VBZ	O	0	ROOT	-1
3	proposed	propose	I-VP	VBN	O	2	VC	-1
4	that	that	B-SBAR	IN	O	3	VMOD	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	switch	switch	I-NP	NN	O	12	SUB	-1
7	from	from	B-PP	IN	O	6	NMOD	-1
8	tumor	tumor	B-NP	NN	B-protein	9	NMOD	-1
9	suppressor	suppressor	I-NP	NN	I-protein	7	PMOD	0
10	to	to	B-PP	TO	O	6	NMOD	-1
11	oncogene	oncogene	B-NP	NN	B-DNA	10	PMOD	-1
12	reflects	reflect	B-VP	VBZ	O	4	SBAR	-1
13	genetic	genetic	B-NP	JJ	O	16	NMOD	-1
14	or	or	I-NP	CC	O	16	NMOD	-1
15	epigenetic	epigenetic	I-NP	JJ	O	16	NMOD	-1
16	alterations	alteration	I-NP	NNS	O	12	OBJ	0
17	in	in	B-PP	IN	O	16	NMOD	-1
18	signaling	signaling	B-NP	NN	O	19	NMOD	0
19	pathways	pathway	I-NP	NNS	O	17	PMOD	0
20	in	in	B-PP	IN	O	19	NMOD	-1
21	tumor	tumor	B-NP	NN	B-cell_type	22	NMOD	-1
22	cells	cell	I-NP	NNS	I-cell_type	20	PMOD	-1
23	that	that	B-NP	WDT	O	22	NMOD	-1
24	alter	alter	B-VP	VBP	O	23	SBAR	16	alter
25	the	the	B-NP	DT	O	26	NMOD	-1
26	readout	readout	I-NP	NN	O	24	OBJ	-1
27	from	from	B-PP	IN	O	26	NMOD	-1
28	the	the	B-NP	DT	O	30	NMOD	-1
29	TGFbeta1	TGFbeta1	I-NP	NN	B-protein	30	NMOD	-1
30	pathway	pathway	I-NP	NN	O	27	PMOD	0
31	.	.	O	.	O	2	P	-1

